Clinical Trials Directory

Trials / Completed

CompletedNCT04930952

Complications of Ethanol-amine Oleate Intralesional Sclerotherapy

Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous Malformations in Pediatric Patients

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Suez Canal University · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers

Summary

The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations in pediatric patients

Detailed description

Maxillofacial Venous malformations cause many functional and esthetic complications in children, intralesional sclerotherapy is the best choice of treatment; and Ethanol-amine Oleate has been the most commonly used sclerosing agent. The aim of this study is to clarify complications of Ethanolamine Oleate intralesional injections of maxillofacial venous formations

Conditions

Interventions

TypeNameDescription
DRUGEthanol-amine Oleate Sclerotherapy InjectionIntralesional Sclerotherapy Injection

Timeline

Start date
2019-02-28
Primary completion
2021-02-28
Completion
2021-03-03
First posted
2021-06-18
Last updated
2021-06-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04930952. Inclusion in this directory is not an endorsement.